Skip to content

FDA OK’s additional doses of Lilly’s Trulicity for type 2 diabetes

September 4, 2020

The FDA has approved two additional doses of Eli Lilly’s (NYSE:LLY) Trulicity (dulaglutide). The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11.

Trulicity is a prescription medicine for adults with type 2 diabetes used to improve blood sugar and to reduce the risk of major cardiovascular events.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: